Stock News

Pomelo Capital Maintains Position in Valeant Pharmaceuticals Intl (Put) (VRX); Bank Of Stockton Continues to Hold Holding in Cigna (CI)

Bank Of Stockton increased its stake in Cigna Corporation (CI) by 42.77% based on its latest 2017Q3 regulatory filing with the SEC. Bank Of Stockton bought 2,363 shares as the company’s stock rose 11.09% with the market. The institutional investor held 7,888 shares of the medical specialities company at the end of 2017Q3, valued at $1.47 million, up from 5,525 at the end of the previous reported quarter. Bank Of Stockton who had been investing in Cigna Corporation for a number of months, seems to be bullish on the $54.33 billion market cap company. The stock increased 2.61% or $5.61 during the last trading session, reaching $220.36. About 1.41 million shares traded or 7.35% up from the average. Cigna Corporation (NYSE:CI) has risen 23.57% since January 18, 2017 and is uptrending. It has outperformed by 6.87% the S&P500.

Philip Rosenstrach increased its stake in Valeant Pharmaceuticals Intl (Put) (VRX) by 375.95% based on its latest 2017Q3 regulatory filing with the SEC. Pomelo Capital Llc bought 827,100 shares as the company’s stock declined 15.71% while stock markets rallied. The hedge fund run by Philip Rosenstrach held 1.05M shares of the health care company at the end of 2017Q3, valued at $15.01 million, up from 220,000 at the end of the previous reported quarter. Pomelo Capital Llc who had been investing in Valeant Pharmaceuticals Intl (Put) for a number of months, seems to be bullish on the $7.91 billion market cap company. The stock decreased 1.22% or $0.28 during the last trading session, reaching $22.7. About 11.42 million shares traded. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has declined 48.51% since January 18, 2017 and is downtrending. It has underperformed by 65.21% the S&P500.

Among 27 analysts covering Valeant Pharmaceuticals Intl (NYSE:VRX), 6 have Buy rating, 5 Sell and 16 Hold. Therefore 22% are positive. Valeant Pharmaceuticals Intl had 150 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Equal-Weight” rating on Monday, March 21 by Barclays Capital. The stock of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has “Buy” rating given on Wednesday, November 11 by Stifel Nicolaus. The stock has “Hold” rating by BMO Capital Markets on Monday, October 30. The company was maintained on Thursday, November 10 by Morgan Stanley. The company was maintained on Thursday, May 11 by Stifel Nicolaus. On Friday, February 10 the stock rating was maintained by Barclays Capital with “Equal Weight”. The company was maintained on Wednesday, May 10 by RBC Capital Markets. The rating was maintained by Scotia Capital on Wednesday, October 14 with “Sector Outperform”. The stock has “Outperform” rating by RBC Capital Markets on Tuesday, October 27. The firm has “Buy” rating given on Monday, September 25 by Cantor Fitzgerald.

Investors sentiment decreased to 0.99 in 2017 Q3. Its down 0.09, from 1.08 in 2017Q2. It turned negative, as 43 investors sold VRX shares while 68 reduced holdings. 27 funds opened positions while 83 raised stakes. 169.87 million shares or 1.18% less from 171.89 million shares in 2017Q2 were reported. Bb&T Secs Ltd Liability Co reported 0.01% stake. Citigroup Inc has invested 0.01% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Parallax Volatility Advisers LP stated it has 0% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Old Second National Bank & Trust Of Aurora owns 1,100 shares. 3,854 are owned by Pinebridge Invests Limited Partnership. Toronto Dominion Fincl Bank accumulated 4.14M shares or 0.19% of the stock. Parametric Ltd Liability Corp holds 0.02% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX) or 980,919 shares. Andra Ap stated it has 0.04% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Germany-based Dekabank Deutsche Girozentrale has invested 0.01% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Moreover, Fincl Svcs Corporation has 0% invested in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Highlander Cap Ltd Llc invested 0.14% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Live Your Vision Limited Com has invested 0% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Teacher Retirement Systems Of Texas accumulated 225,900 shares. Cannell Peter B And Inc holds 0.75% or 1.50M shares in its portfolio. The Pennsylvania-based Glenmede Trust Na has invested 0% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX).

Pomelo Capital Llc, which manages about $366.34 million and $2.35 billion US Long portfolio, decreased its stake in Tenet Healthcare Corp (NYSE:THC) by 330,328 shares to 133,472 shares, valued at $2.19 million in 2017Q3, according to the filing. It also reduced its holding in Freeport (NYSE:FCX) by 4.89M shares in the quarter, leaving it with 100,000 shares, and cut its stake in Chesapeake Energy Corp (NYSE:CHK).

Since August 7, 2017, it had 0 insider buys, and 9 insider sales for $13.93 million activity. On Monday, August 7 the insider Sadler Jason D sold $6.65M. $43,604 worth of Cigna Corporation (NYSE:CI) shares were sold by ZOLLARS WILLIAM D. Shares for $402,366 were sold by Bacus Lisa R. Another trade for 525 shares valued at $93,232 was made by Hoeltzel Mary T on Wednesday, August 9. Shares for $5.77 million were sold by MURABITO JOHN M. The insider Triplett Michael W sold 3,700 shares worth $647,360.

Investors sentiment is 0.96 in Q3 2017. Its the same as in 2017Q2. It is the same, as 47 investors sold CI shares while 249 reduced holdings. only 72 funds opened positions while 212 raised stakes. 206.32 million shares or 5.35% less from 217.98 million shares in 2017Q2 were reported. Tokio Marine Asset reported 2,236 shares stake. Axa reported 220,462 shares. Signature Mngmt holds 1,412 shares. Brighton Jones invested 0.03% in Cigna Corporation (NYSE:CI). 4,563 are held by Aviance Cap Prtnrs Lc. Northcoast Asset Management holds 1.64% or 74,466 shares. Blair William Il stated it has 7,664 shares or 0.01% of all its holdings. Founders Capital Mgmt Ltd Liability Com holds 0.2% in Cigna Corporation (NYSE:CI) or 2,268 shares. Reynders Mcveigh Cap Mngmt Limited Co accumulated 1,465 shares. Los Angeles Capital And Equity Rech accumulated 0.25% or 231,072 shares. The New York-based Alliancebernstein Lp has invested 0.39% in Cigna Corporation (NYSE:CI). First Tru Advsrs Lp has 0.06% invested in Cigna Corporation (NYSE:CI). Johnson Fin Grp reported 1,373 shares stake. Moreover, Bokf Na has 0.03% invested in Cigna Corporation (NYSE:CI). Lombard Odier Asset Mgmt (Switzerland) Sa reported 2.16% stake.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *